Satyavrat Shukla

CFO

CEO Board Member CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$244,153	$452,813	$603,380	—	$307,912	$416,919	$2,025,178
2024	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$603,750	—	$1,066,817	—	$271,686	$10,984	$1,953,237
2023	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$524,383	$336,000	$904,319	—	$249,462	$10,483	$2,024,648
2022	Spero Therapeutics, Inc. (SPRO)	President and Chief Executive Officer	$478,333	$168,000	$424,997	$424,807	$172,800	$4,133	$1,673,070
2021	Spero Therapeutics, Inc. (SPRO)	President and Chief Executive Officer and Former Chief Financial Officer and Treasurer	$440,889	$164,000	$399,994	$1,039,433	$175,660	$8,295	$2,228,271
2020	Spero Therapeutics, Inc. (SPRO)	Chief Financial Officer	—	—	—	—	—	—	—

Executive changes

Appointed Class II director on the Board at Spero Therapeutics, Inc. (SPRO)
2023-08-01
Appointed Chief Executive Officer and President at Spero Therapeutics, Inc. (SPRO)
2023-08-01

Earnings-call appearances

Spero Therapeutics, Inc. Q4 FY2022 Earnings Call
Spero Therapeutics, Inc. (SPRO)

2023-01-09
Spero Therapeutics, Inc. Q2 FY2021 Earnings Call
Spero Therapeutics, Inc. (SPRO)

2021-08-05